BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29166620)

  • 1. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
    Zhen Y; Zhang Y; Yu Y
    Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
    Hopp AK; Hottiger MO
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.
    Li P; Zhen Y; Yu Y
    Methods Enzymol; 2019; 626():301-321. PubMed ID: 31606080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis.
    Kim DS; Challa S; Jones A; Kraus WL
    Genes Dev; 2020 Mar; 34(5-6):302-320. PubMed ID: 32029452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine ADP-ribosylation reversal by the hydrolase ARH3.
    Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
    Elife; 2017 Jun; 6():. PubMed ID: 28650317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomics analysis of the NAD
    Jones A; Kraus WL
    Genes Dev; 2022 May; 36(9-10):601-617. PubMed ID: 35654456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying Catabolism of Protein ADP-Ribosylation.
    Palazzo L; James DI; Waddell ID; Ahel I
    Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of regulaion of transcription by PARP1].
    Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
    Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Protein ADP-Ribosylation Using a Clickable Aminooxy Probe.
    Morgan RK; Cohen MS
    Methods Mol Biol; 2017; 1608():71-77. PubMed ID: 28695504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
    Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
    Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PARP Way to Epigenetic Changes.
    Ummarino S; Hausman C; Di Ruscio A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ADP-Ribose Acceptor Sites on In Vitro Modified Proteins by Liquid Chromatography-Tandem Mass Spectrometry.
    Leutert M; Bilan V; Gehrig P; Hottiger MO
    Methods Mol Biol; 2017; 1608():137-148. PubMed ID: 28695508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting and Quantifying pADPr In Vivo.
    Lai YC; Aneja RK; Satchell MA; Clark RSB
    Methods Mol Biol; 2017; 1608():27-43. PubMed ID: 28695501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA maintenance following bleomycin-induced strand breaks does not require poly(ADP-ribosyl)ation activation in Drosophila S2 cells.
    Ishak L; Moretton A; Garreau-Balandier I; Lefebvre M; Alziari S; Lachaume P; Morel F; Farge G; Vernet P; Dubessay P
    DNA Repair (Amst); 2016 Dec; 48():8-16. PubMed ID: 27793508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a "Clickable" NAD
    Gibson BA; Kraus WL
    Methods Mol Biol; 2017; 1608():111-135. PubMed ID: 28695507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast Cancer.
    Krishnan A; Spegg V; Dettwiler S; Schraml P; Moch H; Dedes K; Varga Z; Altmeyer M
    Mod Pathol; 2023 Jul; 36(7):100167. PubMed ID: 36990278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method.
    Daniels CM; Ong SE; Leung AKL
    Methods Mol Biol; 2017; 1608():79-93. PubMed ID: 28695505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.